Despite the majority of states allowing medical cannabis use, cannabis leads drug-related prosecutions in the U.S by a significant margin. Over 650,000 people were arrested for […]
Historic Massachusetts farm cultivates medical cannabis with a social conscience By Michael Harlow, CPA, Partner Beginning decades ago, George and Joanne Patton, son and daughter-in-law of […]
By J.J. McCoy, Senior Managing Editor for New Frontier Data New research from New Frontier Data finds that cannabis arrests account for 41.6% of all drug-related […]
The FDA last week approved UK-based GW Pharmaceuticals’ Epidiolex, a “pure plant-derived CBD” extract shown to drastically reduce seizures in children with epileptic syndromes. Marking the […]
More than a dozen states are expected pass new cannabis legalization measures before 2025. Of them, four are expected to open medical markets, while nine may […]
By J.J. McCoy, Senior Managing Editor for New Frontier Data Judging by a flurry of anxious headlines this month, the U.S. Congress (with President Trump’s “probable” […]
By Yona Torres, Editor, New Frontier Data As exiting opportunities arise from the Canadian cannabis market, investors should be aware of five key risks and exposures […]
$23.9 billion The top 10 publicly traded U.S. cannabis companies are valued at $8.2 billion collectively, (CAD 23.9 billion), as illustrated here last week. Scotts Miracle-Gro […]
By Jordan Wellington, Simplyfya Cofounder and Chief Compliance Officer In many ways, working as a budtender is similar to working at other types of retail establishments. […]